Gray Foundation’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.36M Hold
37,800
– – 1.25% 7
2026
Q2
$6.37M Hold
37,800
– – 1.4% 8
2026
Q1
$4.98M Hold
37,800
– – 1.26% 10
2025
Q4
$5.36M Buy
+37,800
New +$5.48M 1.35% 10

Other funds holding NBIX

Gray Foundation's NBIX Position: Q3 2026 in Review

Gray Foundation held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 37,800 shares worth $5.36M. The position accounts for 1.25% of the portfolio, ranked #7.

Gray Foundation first reported a position in NBIX in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.37M in Q2 2026. 772 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Gray Foundation held 37,800 shares of Neurocrine Biosciences worth $5.36M as of Q3 2026.
  • Gray Foundation left its Neurocrine Biosciences share count unchanged in Q3 2026.
  • Neurocrine Biosciences made up 1.25% of Gray Foundation's portfolio in Q3 2026, its #7 holding.
  • Gray Foundation first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 4 quarters since.
  • Gray Foundation's Neurocrine Biosciences position peaked at $6.37M in Q2 2026.
  • 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Gray Foundation's 13F filing for Q3 2026, filed 10 Nov 2026.